AAAAAA

   
Results: 1-9 |
Results: 9
CHRONIC MYELOGENOUS LEUKEMIA TERMINATING IN ACUTE MEGAKARYOBLASTIC LEUKEMIA - CASE-REPORT
Authors: BOURANTAS KL REPOUSIS P TSIARA S CHRISTOU L KONSTANTINIDOU P BAI M
Citation: Kl. Bourantas et al., CHRONIC MYELOGENOUS LEUKEMIA TERMINATING IN ACUTE MEGAKARYOBLASTIC LEUKEMIA - CASE-REPORT, Journal of experimental & clinical cancer research, 17(2), 1998, pp. 243-245
CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: KONSTANTINIDOU P SZYDLO RM CHASE A GOLDMAN JM
Citation: P. Konstantinidou et al., CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 302-302
OSTEOPOROSIS IN THALASSEMIA
Authors: AGGELAKI M KONSTANTINIDOU P MOLIVTHA E PAPALOANNOU E VAINAS H ZACHARAKI R
Citation: M. Aggelaki et al., OSTEOPOROSIS IN THALASSEMIA, British Journal of Haematology, 102(1), 1998, pp. 54-54
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN CHRONIC MYELOGENOUS LEUKEMIA
Authors: BOURANTAS KL TSIARA S MAKIS A CHAIDOS A CHRISTOU L KONSTANTINIDOU P KOLIOS G SEFERIADIS K
Citation: Kl. Bourantas et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN CHRONIC MYELOGENOUS LEUKEMIA, European journal of haematology, 59(4), 1997, pp. 263-265
SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA FOLLOWING FLUDARABINE THERAPY IN APATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: TSIARA S CHRISTOU L KONSTANTINIDOU P PANTELI A BRIASOULIS E BOURANTAS KL
Citation: S. Tsiara et al., SEVERE AUTOIMMUNE HEMOLYTIC-ANEMIA FOLLOWING FLUDARABINE THERAPY IN APATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, American journal of hematology, 54(4), 1997, pp. 342-342
RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: BOURANTAS K TSIARA S KONSTANTINIDOU P MITSULISMENTSIKOFF V CHRISTOU L
Citation: K. Bourantas et al., RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MULTIPLE-MYELOMA, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 371-374
RHEUMATIC MANIFESTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: BOURANTAS KL TSIARA S KONSTANTINIDOU P REPOUSIS P GEORGOPOULOS A CHRISTOU L
Citation: Kl. Bourantas et al., RHEUMATIC MANIFESTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Journal of experimental & clinical cancer research, 15(4), 1996, pp. 405-410
COMBINATION THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, INTERFERON-ALPHA-2B AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN IDIOPATHIC MYELOFIBROSIS
Authors: BOURANTAS KL TSIARA S CHRISTOU L REPOUSIS P KONSTANTINIDOU P BAI M SEFERIADIS K
Citation: Kl. Bourantas et al., COMBINATION THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, INTERFERON-ALPHA-2B AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN IDIOPATHIC MYELOFIBROSIS, Acta haematologica, 96(2), 1996, pp. 79-82
5 CASES OF NONSECRETORY MULTIPLE-MYELOMA
Authors: BOURANTAS K KLOUVAS G NICOLAIDES C KONSTANTINIDOU P TZALAS C BAI M
Citation: K. Bourantas et al., 5 CASES OF NONSECRETORY MULTIPLE-MYELOMA, Journal of experimental & clinical cancer research, 14(4), 1995, pp. 431-434
Risultati: 1-9 |